NCT00307840View on ClinicalTrials.gov

Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

February 28, 2005

Study Completion Date

July 31, 2005

Conditions

Secondary Hyperparathyroidism

Interventions

DRUG

paricalcitol

All Listed Sponsors

lead

Papageorgiou General Hospital

OTHER

NCT00307840 - Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism | Biotech Hunter | Biotech Hunter